Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...

Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...

The NSE Nifty 50 ended 205.4 points or 0.81% lower at 25,149.85, while the BSE Sensex closed 689.81 points, or 0.83% down at 82,500.47 on Friday.

The local share market pulled back from yesterday's record close, with the big banks dragging the broader index down, while rare earths stocks rallied. The long-expected rise in tariff-inspired ...

The ASX bounced back from a shaky start as Trump’s tariff blitz rattled markets, but Nvidia soared, Bitcoin buzzed, and DroneShield surged.

Rising fuel and food costs behind surprise rise - Latest on UK figures data plus stock markets updates, business and money ...

A rally in big tech stocks led the broader market to a higher close Wednesday, lifting the Nasdaq to an all-time high and ...

President Joe Biden on Friday afternoon signs an executive order that seeks to rein in the power of big business, with the much-anticipated measure targeting agriculture, banking, tech ...

The panel’s top Democrat Sen. Richard Blumenthal, D-Conn., shared Johnson’s concerns of big pharma and pledged to co-sponsor ...

The chief financial officer and a manager of a failed digital pharmacy company must defend against some federal regulator ...

A generous grace period would give drugmakers time to sidestep most of the pain of looming duties.